Opioid Diversion, Postal Carrier Dangers Among Industry Concerns With Mail-Back Envelope Requirement

 
• By Derrick Gingery
  
Pills in envelope
Industry trade groups raised several concerns about an FDA proposal to require pre-paid mail-back disposal envelopes with all opioid prescriptions. • Source: Shutterstock

More from Drug Safety

More from Pink Sheet